These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23195239)

  • 21. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial.
    Ihl R; Tribanek M; Bachinskaya N;
    Pharmacopsychiatry; 2012 Mar; 45(2):41-6. PubMed ID: 22086747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of xantinolnicotinate in patients with dementia.
    Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
    Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No significant effect of ginkgo biloba special extract EGb 761 in the treatment of primary Raynaud phenomenon: a randomized controlled trial.
    Bredie SJ; Jong MC
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):215-21. PubMed ID: 22030896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.
    Gutzmann H; Kühl KP; Hadler D; Rapp MA
    Pharmacopsychiatry; 2002 Jan; 35(1):12-8. PubMed ID: 11819153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of Depression, Anxiety and Cognition on the Treatment Effects of
    Brüggemann P; Sória MG; Brandes-Schramm J; Mazurek B
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia.
    Hashiguchi M; Ohta Y; Shimizu M; Maruyama J; Mochizuki M
    J Pharm Health Care Sci; 2015; 1():14. PubMed ID: 26819725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H
    Fortschr Neurol Psychiatr; 2009 Sep; 77(9):494-506. PubMed ID: 19621278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
    Görtelmeyer R; Erbler H
    Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Ong PA; Yuda T; Ng LL; Mamun K; Merchant RA; Chen C; Dominguez J; Marasigan S; Ampil E; Nguyen VT; Yusoff S; Chan YF; Yong FM; Krairit O; Suthisisang C; Senanarong V; Ji Y; Thukral R; Ihl R
    CNS Neurosci Ther; 2019 Feb; 25(2):288-298. PubMed ID: 30648358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.
    Wettstein A
    Phytomedicine; 2000 Jan; 6(6):393-401. PubMed ID: 10755847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Hort J; Duning T; Hoerr R
    Neuropsychiatr Dis Treat; 2023; 19():647-660. PubMed ID: 36994422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmaco-economic evaluation of Ginkgo special extract EGb 761 for dementias in Austria].
    Hörr R; Kieser M
    Wien Med Wochenschr; 2002; 152(15-16):427-31. PubMed ID: 12244892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ginkgo biloba special extract EGb 761--an anti-dementia drug].
    Hörr R; Kieser M
    Fortschr Med; 1998 Jan; 116(3):39-40. PubMed ID: 9522547
    [No Abstract]   [Full Text] [Related]  

  • 38. Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam.
    Herrmann WM; Stephan K
    Int Psychogeriatr; 1992; 4(1):25-44. PubMed ID: 1391670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild Cognitive Impairment and Mild Dementia: The Role of
    Tomino C; Ilari S; Solfrizzi V; Malafoglia V; Zilio G; Russo P; Proietti S; Marcolongo F; Scapagnini G; Muscoli C; Rossini PM
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33915701
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    McKeage K; Lyseng-Williamson KA
    Drugs Ther Perspect; 2018; 34(8):358-366. PubMed ID: 30546253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.